Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia.

Thoracic cancer·2025
Same author

An update on adjuvant systemic therapies in melanoma.

Melanoma management·2019
Same author

Nemaline rod and central core disease: a coexisting Z-band myopathy.

Muscle & nerve·1997
Same author

Occurrence of myeloproliferative disorder in patients with Noonan syndrome.

The Journal of pediatrics·1997
Same author

Left lateralized P300 amplitude deficit in schizophrenic patients depends on pitch disparity.

Biological psychiatry·1997
Same author

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease.

Nature medicine·1997

相关实验视频

Updated: Sep 19, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201

在可切除非小细胞肺癌 (NSCLC) 中优化术前临床分期:一项回顾性队列研究.

E Samuel1,2, C Thomas3, C Thompson4

  • 1School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Thoracic cancer
|June 16, 2025
PubMed
概括

准确的分期对于非小细胞肺癌 (NSCLC) 治疗至关重要. 许多患者在临床和病理阶段之间存在差异,结节阶段不一致影响生存,需要改进手术前评估.

关键词:
在NSCLCLC中,我们可以看到NSCLCLC.不和 不和 不和移民 移民 迁移 迁移质量指标 质量指标风险预测风险预测阶段一致性 阶段一致性

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381

相关实验视频

Last Updated: Sep 19, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381

科学领域:

  • 在瘤学瘤学.
  • 胸部外科手术 胸部外科手术
  • 医疗成像医学成像

背景情况:

  • 准确的手术前临床分期对于指导可切除非小细胞肺癌 (NSCLC) 治疗决策至关重要.
  • 临床和病理阶段之间的差异可能导致不适当的治疗选择.
  • 这项研究调查了NSCLC患者的分期精度,不一致性预测因子和生存结果.

研究的目的:

  • 评估可切除NSCLC的临床和病理阶段之间的一致率.
  • 确定预测临床病理阶段不一致的因素.
  • 评估分期差异对患者存活时间的影响.

主要方法:

  • 进行手术切除的I-IIIA期NSCLC患者的回顾性队列研究 (2011-2020年).
  • 基于CT,PET和节点评估的临床分期;基于手术组织学的病理分期.
  • 多变量后勤和考克斯回归模型用于分析不一致性和生存的预测因素.

主要成果:

  • 在221名患者中,58%的患者具有一致的临床和病理阶段;42%的患者表现出不一致 (23.9%升级,17.2%降级).
  • N-阶段一致性与女性性别,瘤组织学,SUVmax和CT-to-surgery间隔有关.
  • 节点阶段异调独立预测了更差的生存率 (HR 0.43,p=0.01).

结论:

  • 在切除性NSCLC的临床和病理阶段之间存在显著的差异.
  • 节点阶段异调是NSCLC患者死亡率的关键预测因素.
  • 需要改进手术前分期策略,以确保符合指南的护理,并优化患者的治疗结果.